Research / CL / Fundamental state Inspectable configuration
State dimensions Filing 0000021665-24-000003 General Corporate
Debt relative to revenue 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
42.34% · OPTIONAL · VALID
Capex intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.62% · OPTIONAL · VALID
Operating cash generation 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.25% · OPTIONAL · VALID
Revenue growth 85th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
8.29% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
9.94% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
58.21% · CORE · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
20.48% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.76% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.63% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 37 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 177.13%
Current 42.34%
Delta -134.79% Capex Intensity Increased
Previous 3.28%
Current 3.62%
Delta 0.35% Cash Generation Decreased
Previous 23.44%
Current 19.25%
Delta -4.19% Growth Decreased
Previous 10.33%
Current 8.29%
Delta -2.03% Inventory Pressure Decreased
Previous 39.29%
Current 9.94%
Delta -29.35% Margin Decreased
Previous 58.53%
Current 58.21%
Delta -0.32% Profitability Decreased
Previous 20.94%
Current 20.48%
Delta -0.46% Sbc Intensity Decreased
Previous 1.22%
Current 0.63%
Delta -0.59% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.